[Dynamics of epileptiform activity, efficacy and tolerability of valproic acid in adults and adolescents with newly-diagnosed epilepsy].

V A Karlov A B Kozhokaru Pavel Vlasov T N Pushkar A S Orlova

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)

VA remains one of the drugs of choice in IGE and FE. EAI may become an additional objective test in cases of difficult differential diagnosis in IGE and FE, using total EAI, EAI before sleep, during sleep, during partial awakenings in the first months of treatment (1-3 months). EAI objectively reflects the dynamics of VA treatment efficacy.

Keyphrases

physical activity
newly diagnosed
young adults
sleep quality
open label
depressive symptoms